Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 3Hypertension, Portal 2Motor Activity 1Liver Diseases 1Liver Cirrhosis 1Hepatocellular Carcinoma with PVTT 1Gastrointestinal Neoplasms 1Breast Neoplasms 1Ascites 1

Interventions

Sorafenib 5Blood Specimen Collection 4lenvatinib 3sintilimab 2pembrolizumab 2ledipasvir, sofosbuvir drug combination 2halofantrine 2camrelizumab 2atezolizumab 2Liver Transplantation 2Immunotherapy 2Control Groups 2Bevacizumab 2Antibodies 2veliparib 1trifluridine tipiracil drug combination 1trametinib 1toripalimab 1titanium silicide 1tislelizumab 1rubitecan 1repotrectinib 1pevonedistat 1ozanimod 1linifanib 1genexol-PM 1gadolinium ethoxybenzyl DTPA 1fluorocholine 1fisogatinib 1ficlatuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Diseases × Portasystemic Shunt, Transjugular Intrahepatic × Clear all
NCT04640116 2020-12-19

TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites

Sun Yat-sen University

Phase NA Unknown
30 enrolled
Gastrointestinal

Ascites, Carcinoma, Hepatocellular, Hypertension, Portal, Liver Cirrhosis, Liver Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡